154 related articles for article (PubMed ID: 33883825)
1. Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.
Watanabe A; Ohata K; Oikawa T; Sugaya T; Miyazaki M; Satoh H; Katayama M
Can J Vet Res; 2021 Apr; 85(2):156-160. PubMed ID: 33883825
[TBL] [Abstract][Full Text] [Related]
2. Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease.
Katayama M; Ohata K; Miyazaki T; Katayama R; Wakamatsu N; Ohno M; Yamashita T; Oikawa T; Sugaya T; Miyazaki M
J Vet Intern Med; 2020 Mar; 34(2):761-769. PubMed ID: 32087614
[TBL] [Abstract][Full Text] [Related]
3. Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats: Evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria.
Kongtasai T; Paepe D; Mortier F; Marynissen S; Meyer E; Duchateau L; Daminet S
Vet Med Sci; 2023 Jan; 9(1):3-12. PubMed ID: 36418182
[TBL] [Abstract][Full Text] [Related]
4. Liver-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin in cats with chronic kidney disease and hyperthyroidism.
Kongtasai T; Meyer E; Paepe D; Marynissen S; Smets P; Mortier F; Demeyere K; Vandermeulen E; Stock E; Buresova E; Defauw P; Duchateau L; Daminet S
J Vet Intern Med; 2021 May; 35(3):1376-1388. PubMed ID: 33723886
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study.
Katayama M; Miyazaki T; Ohata K; Oikawa T; Kamiie J; Sugaya T; Miyazaki M
J Vet Med Sci; 2019 Dec; 81(12):1868-1872. PubMed ID: 31645505
[TBL] [Abstract][Full Text] [Related]
6. Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease.
Thanaboonnipat C; Sutayatram S; Buranakarl C; Choisunirachon N
BMC Vet Res; 2019 Feb; 15(1):54. PubMed ID: 30744640
[TBL] [Abstract][Full Text] [Related]
7. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease.
Kamijo A; Sugaya T; Hikawa A; Yamanouchi M; Hirata Y; Ishimitsu T; Numabe A; Takagi M; Hayakawa H; Tabei F; Sugimoto T; Mise N; Omata M; Kimura K
Mol Cell Biochem; 2006 Mar; 284(1-2):175-82. PubMed ID: 16532260
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial.
Kamijo A; Sugaya T; Hikawa A; Yamanouchi M; Hirata Y; Ishimitsu T; Numabe A; Takagi M; Hayakawa H; Tabei F; Sugimoto T; Mise N; Kimura K
J Lab Clin Med; 2005 Mar; 145(3):125-33. PubMed ID: 15871303
[TBL] [Abstract][Full Text] [Related]
9. Urinary F
Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
[TBL] [Abstract][Full Text] [Related]
10. Urine liver fatty acid binding protein and chronic kidney disease progression.
Khatir DS; Bendtsen MD; Birn H; Nørregaard R; Ivarsen P; Jespersen B; Buus NH
Scand J Clin Lab Invest; 2017 Nov; 77(7):549-554. PubMed ID: 28745927
[TBL] [Abstract][Full Text] [Related]
11. Renal biomarkers in cats: A review of the current status in chronic kidney disease.
Kongtasai T; Paepe D; Meyer E; Mortier F; Marynissen S; Stammeleer L; Defauw P; Daminet S
J Vet Intern Med; 2022 Mar; 36(2):379-396. PubMed ID: 35218249
[TBL] [Abstract][Full Text] [Related]
12. Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.
Fujita D; Takahashi M; Doi K; Abe M; Tazaki J; Kiyosue A; Myojo M; Ando J; Fujita H; Noiri E; Sugaya T; Hirata Y; Komuro I
Heart Vessels; 2015 May; 30(3):296-303. PubMed ID: 24554034
[TBL] [Abstract][Full Text] [Related]
13. Kidney function and glucose metabolism in overweight and obese cats.
Pérez-López L; Boronat M; Melián C; Brito-Casillas Y; Wägner AM
Vet Q; 2020 Dec; 40(1):132-139. PubMed ID: 32315583
[No Abstract] [Full Text] [Related]
14. Routine kidney variables, glomerular filtration rate and urinary cystatin C in cats with diabetes mellitus, cats with chronic kidney disease and healthy cats.
Paepe D; Ghys LF; Smets P; Lefebvre HP; Croubels S; Daminet S
J Feline Med Surg; 2015 Oct; 17(10):880-8. PubMed ID: 25425599
[TBL] [Abstract][Full Text] [Related]
15. Urine hemojuvelin in cats with naturally occurring kidney disease.
Jing H; Hsu WL; Wu VC; Tsai HJ; Tsai SF; Tsai PJ; Lai TS; Lee YJ
J Vet Intern Med; 2020 May; 34(3):1222-1230. PubMed ID: 32324955
[TBL] [Abstract][Full Text] [Related]
16. Urinary heat shock protein-72: A novel marker of acute kidney injury and chronic kidney disease in cats.
Chen H; Avital Y; Bruchim Y; Aroch I; Segev G
Vet J; 2019 Jan; 243():77-81. PubMed ID: 30606443
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.
Mou S; Wang Q; Li J; Shi B; Ni Z
Clin Chim Acta; 2012 Jan; 413(1-2):187-91. PubMed ID: 21958699
[TBL] [Abstract][Full Text] [Related]
18. Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease.
Mitsides N; Mitra V; Saha A; Harris S; Kalra PA; Mitra S
J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888092
[TBL] [Abstract][Full Text] [Related]
19. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease.
Habenicht LM; Webb TL; Clauss LA; Dow SW; Quimby JM
J Feline Med Surg; 2013 Feb; 15(2):99-104. PubMed ID: 22989558
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.
Xie Y; Xue W; Shao X; Che X; Xu W; Ni Z; Mou S
PLoS One; 2014; 9(11):e112865. PubMed ID: 25402279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
